Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial




Joensuu H, Sailas L, Alanko T, Sunela K, Huuhtanen R, Utriainen M, Kokko R, Bono P, Wigren T, Pyrhönen S, Turpeenniemi-Hujanen T, Asola R, Leinonen M, Hahka-Kemppinen M, Kellokumpu-Lehtinen P

2010

Annals of Oncology

5

21

5

968

973

6

0923-7534

DOIhttps://doi.org/10.1093/annonc/mdp397




Last updated on 2024-26-11 at 21:46